Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Curr Med Sci ; 41(5): 847-856, 2021 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-34652631

RESUMO

OBJECTIVE: To determine whether B vitamin treatment was sufficient to reduce cognitive impairment associated with high-fat diets in rats and to modulate transketolase (TK) expression and activity. METHODS: To test this, we separated 50 rats into five groups that were either fed a standard chow diet (controls) or a high-fat diet (experimental groups H0, H1, H2, and H3). H0 group animals received no additional dietary supplementation, while H1 group animals were administered 100 mg/kg body weight (BW) thiamine, 100 mg/kg BW riboflavin, and 250 mg/kg BW niacin each day, and group H2 animals received daily doses of 100 mg/kg BW pyridoxine, 100 mg/kg BW cobalamin, and 5 mg/kg BW folate. Animals in the H3 group received the B vitamin regimens administered to both H1 and H2 each day. RESULTS: Over time, group H0 exhibited greater increases in BW and fat mass relative to other groups. When spatial and memory capabilities in these animals were evaluated via conditioned taste aversion (CTA) and Morris Water Maze (MWM), we found B vitamin treatment was associated with significant improvements relative to untreated H0 controls. Similarly, B vitamin supplementation was associated with elevated TK expression in erythrocytes and hypothalamus of treated animals relative to those in H0 (P<0.05). CONCLUSION: Together, these findings suggest B vitamin can modulate hypothalamic TK activity to reduce the severity of cognitive deficits in a rat model of obesity. As such, B vitamin supplementation may be a beneficial method for reducing cognitive dysfunction in clinical settings associated with high-fat diets.


Assuntos
Disfunção Cognitiva/tratamento farmacológico , Dieta Hiperlipídica/efeitos adversos , Transcetolase/metabolismo , Complexo Vitamínico B/administração & dosagem , Animais , Disfunção Cognitiva/induzido quimicamente , Disfunção Cognitiva/enzimologia , Suplementos Nutricionais , Modelos Animais de Doenças , Ácido Fólico/administração & dosagem , Ácido Fólico/farmacologia , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Masculino , Teste do Labirinto Aquático de Morris/efeitos dos fármacos , Niacina/administração & dosagem , Niacina/farmacologia , Piridoxina/administração & dosagem , Piridoxina/farmacologia , Ratos , Riboflavina/administração & dosagem , Riboflavina/farmacologia , Tiamina/administração & dosagem , Tiamina/farmacologia , Vitamina B 12/administração & dosagem , Vitamina B 12/farmacologia , Complexo Vitamínico B/farmacologia
2.
Curr Med Sci ; 38(1): 174-183, 2018 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-30074168

RESUMO

B vitamins are enzyme cofactors that play an important role in energy metabolism. The aim of this study was to elucidate whether B vitamin administration can reduce body weight (BW) gain by improving energy metabolism-related enzyme activities in rats fed on a highfat diet. Fifty rats were randomly assigned to one of the following five groups: control group (C), including rats fed on standard rat chow; four treatment groups (HO, HI, H2, and H3), in which rats were fed on a high-fat diet. Rats in the HI group were treated daily with 100 mg/kg BW thiamine (VB1), 100 mg/kg BW riboflavin (VB2), and 250 mg/kg BW niacin (VPP); rats in the H2 group were treated daily with 100 mg/kg BW pyridoxine (VB6), 100 mg/kg BW cobalamin (VB12), and 5 mg/kg BW folate (FA); and rats in the H3 group were treated daily with all of the B vitamins administered to the HI and H2 groups. After 12 weeks, the BW gains from the initial value were 154.5±58.4 g and 159.1±53.0 g in the HI and C groups, respectively, which were significantly less than the changes in the HO group (285.2±14.8 g, P<0.05). In the HO group, the plasma total cholesterol (CHO) and triglyceride (TG) levels were 1.59±0.30 mmol/L and 1,55±0.40 mmol/L, respectively, which were significantly greater than those in the HI group (1.19±0.18 mmol/L and 0.76±0.34 mmol/L, respectively, P<0.05). The activities of transketolase (TK), glutathione reductase, and Na+/K+ adenosine triphosphatase were significantly increased in the B vitamin-treated groups and were significantly greater than those in the HO group (P<0.05). Furthermore, the glucose-6-phosphate dehydrogenase, pyruvic acid kinase, and succinate dehydrogenase activities also were increased after treatment with B vitamins. Supplementation with B vitamins could effectively reduce BW gain and plasma levels of lipids by improving energy metabolism-related enzyme activities in rats, thus possibly providing potential benefits to humans.


Assuntos
Fármacos Antiobesidade/farmacologia , Peso Corporal/efeitos dos fármacos , Obesidade/prevenção & controle , Complexo Vitamínico B/farmacologia , Vitaminas/farmacologia , Animais , Fármacos Antiobesidade/administração & dosagem , Fármacos Antiobesidade/uso terapêutico , Colesterol/sangue , Dieta Hiperlipídica/efeitos adversos , Glucosefosfato Desidrogenase/sangue , Glutationa Redutase/sangue , Masculino , Obesidade/sangue , Obesidade/etiologia , Piruvato Quinase/sangue , Ratos , Ratos Wistar , Transcetolase/sangue , Triglicerídeos/sangue , Complexo Vitamínico B/administração & dosagem , Complexo Vitamínico B/uso terapêutico , Vitaminas/administração & dosagem , Vitaminas/uso terapêutico
3.
Asian Pac J Trop Med ; 7(2): 130-5, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-24461526

RESUMO

OBJECTIVE: To investigate whether there is an association between diameter of bacille Calmette-Guérin (BCG) scars and effect of purified protein derivative (PPD) reaction and to determine whether vitamin A (VA) combined vitamin D (VD) supplementation influences the immune response to BCG revaccinated in Chinese infants. METHODS: A cross-section and 3-month community-randomised trial was conducted. A total of 5 629 infants at 3, 6 and 12 months of age in Junan County of China were examined for BCG scar formation. Then, 597 revaccinated infants were randomly assigned to supplementation (n=307) and control (n=290) groups. The supplementation group were daily assigned to 1 500 IU VA and 500 IU VD for 3 months. Then all infants were subjected to skin test with PPD. RESULTS: The diameter of BCG scars was positively correlated with diameter of skin indurations of PPD (r=0.17, P<0.05) in the 5 629 infants. The rate of positive response to PPD was higher in the supplementation group than in the control group (96.1% versus 89.7%, P<0.05, prevalence ratio 1.07, 95% CI 1.02-1.12). The prevalence ratio of PPD response for the supplementation group compared with that for the control group was 1.07 (95% CI 1.01-1.13) for the males and 1.08 (95% CI 1.00-1.17) for the females. For the supplementation group, the males got larger tuberculin induration than the females [(0.73±0.21) cm versus (0.67±0.20) cm, P<0.05) after intervention. CONCLUSIONS: The diameter of BCG scars was effectively correlated with PPD response, which indicates BCG scar formation may be an useful tool to evaluate the effect of tuberculosis prevention. VA combined VD supplementation may play an immuno-regulatory role in BCG revaccination. This may contribute to the prevention of childhood tuberculosis.


Assuntos
Vacina BCG/administração & dosagem , Vitamina A/administração & dosagem , Vitamina D/administração & dosagem , Fatores Etários , Vacina BCG/imunologia , China , Cicatriz/patologia , Suplementos Nutricionais , Feminino , Humanos , Imunização Secundária/métodos , Lactente , Masculino , Prevalência , Tuberculina/imunologia , Tuberculose/imunologia , Tuberculose/prevenção & controle
4.
Br J Nutr ; 106(11): 1676-82, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21736780

RESUMO

The objective of the present study was to investigate age-related differences in erythrocyte membrane fluidity (EMF) and changes in antioxidant capacity following supplementation. A total of seventy-four children were randomly divided into two groups: group A1 was the placebo-controlled group and group A2 was supplemented daily with 600 µg retinol, 1·0 mg ß-carotene, 100 mg tocopherol, 300 mg ascorbic acid and 200 µg Se. A total of ninety young people were randomly divided into B1 and B2 groups, and ninety-one elderly subjects were divided into C1 and C2 groups. Groups B1 and C1 were placebo-controlled groups, and groups B2 and C2 were daily supplemented with 900 µg retinol, 1·5 mg ß-carotene, 200 mg tocopherol, 500 mg ascorbic acid and 400 µg Se. Results showed that plasma malondialdehyde (MDA) was 5·35 µmol/l in children, which was lower than in young and elderly people. The MDA levels of the young and elderly individuals in the treated groups were significantly lower compared with the control groups, but the supplementation did not alter MDA levels in children. At baseline, there was a lower value of polarisation (ρ) and microviscosity (η) in children, indicating a higher EMF, than in both the young and elderly subjects. After the 2-month trial, the ρ and η values of young and elderly subjects in the treated groups decreased significantly in comparison with the placebo groups, indicating an increase in EMF. In conclusion, there was a background of higher MDA levels and lower EMF in young and elderly people than in children, which could be improved by antioxidant supplementation.


Assuntos
Antioxidantes/administração & dosagem , Suplementos Nutricionais , Membrana Eritrocítica/efeitos dos fármacos , Fluidez de Membrana/efeitos dos fármacos , Micronutrientes/administração & dosagem , População Rural , Adulto , Idoso , Antioxidantes/farmacologia , Criança , Humanos , Malondialdeído/metabolismo , Micronutrientes/farmacologia
5.
Nutr Res ; 29(7): 519-24, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19700040

RESUMO

Although magnesium and vitamin E (VE) have differing effects on diabetes, both are beneficial. We hypothesized that preventive supplementation of magnesium combined with VE could improve the metabolism of lipids and blood viscosity more effectively than the use of magnesium or VE alone. Our objective was to detect the effects of preventive supplementation of magnesium combined with VE on lipid peroxidation, lipid metabolic parameters, and blood viscosity in diabetic rats. Six dietary groups, all fed with high-energy diets, were formed and studied for 8 weeks: control group (C); VE group (E); middle-dose magnesium group (MM); high-dose magnesium group (HM); VE plus middle-dose magnesium group (EMM); and VE plus high-dose magnesium group (EHM). Compared with C group, malondialdehyde was inhibited in the E, EMM, and EHM groups (all P < .05); total cholesterol decreased in all 5 treated groups, and significant differences were found in groups E (P = .004), MM (P = .017), EMM (P = .016), and EHM (P = .020). Compared with the C group, high-density lipoprotein levels were elevated in the HM (P = .027) and EHM (P = .021) groups, and low-density lipoprotein levels were lower in the E (P = .010), EMM (P = .025), and EHM (P = .015) groups. Differences between middle and high shear rates of blood viscosity were significant in all treated groups compared with the C group (all P

Assuntos
Antioxidantes/farmacologia , Viscosidade Sanguínea/efeitos dos fármacos , Diabetes Mellitus Experimental/tratamento farmacológico , Hipolipemiantes/farmacologia , Lipídeos/sangue , Magnésio/farmacologia , Vitamina E/farmacologia , Animais , Colesterol/sangue , Diabetes Mellitus Experimental/sangue , Dieta , Suplementos Nutricionais , Relação Dose-Resposta a Droga , Quimioterapia Combinada , Feminino , Masculino , Malondialdeído/sangue , Ratos , Ratos Wistar
6.
Wei Sheng Yan Jiu ; 34(4): 425-7, 2005 Jul.
Artigo em Chinês | MEDLINE | ID: mdl-16229265

RESUMO

OBJECTIVE: To investigate the influences of vitamin E (VE) at different dosage on peripheral blood lymphocyte (PBL) proliferation and anti-DNA oxidative damage activities and erythrocyte membrane fluidity. METHODS: 48 Wistar rats were randomly divided into four groups including control group, VE1, VE2, and VE3 groups supplemented with 7.5, 50, 200, 750 IU/kg bw x d VE, respectively. The trial lasted 8 weeks and the blood samples were collected at the end of the trial. The level of plasma VE was analyzed by fluorescent spectrometry. Plasma MDA and membrane GSH-Px were analyzed by kits. The blood erythrocyte membrane fluidity was detected by fluorescence polarization method, lymphocyte transformation rate by MTT method and DNA oxidative damage by comet assay. RESULTS: The results showed that plasma VE levels significantly increased in VE1, VE2, and VE3 groups. Plasma MDA and erythocyte membrane GSH-Px activity in the rats in 50 IU/kg bw x d (VE1) group were (2.29 +/- 0.55) nmol/ml and (367.17 +/- 129.86) U/mg prot, respectively. P (fluorescence polarization) and eta(microviscosity), which were inversely related with membrane fluidity, in VE1 group were significantly lower. Lymphocyte transformation rate was significantly increased by 261.86%, 199.23% and 412.97% and H2O2 induced DNA damage significantly decreased compared with the control, VE2, and VE3 groups. CONCLUSION: It is indicated that an effective intake of VE for enhancing erythrocyte membrane fluidity, lymphocyte proliferation and DNA stability was 50 IU/kg bw x d, while too excessive intake of VE could not be found to be beneficial.


Assuntos
Dano ao DNA , Ativação Linfocitária/efeitos dos fármacos , Linfócitos/citologia , Vitamina E/administração & dosagem , Vitamina E/farmacologia , Animais , Membrana Eritrocítica/efeitos dos fármacos , Feminino , Linfócitos/efeitos dos fármacos , Masculino , Fluidez de Membrana/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Ratos , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA